Related Experiment Video
Updated: Sep 8, 2025

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Causal Relationships Between Gastroesophageal Reflux Disease and Myocardial Infarction: Insights From Univariable and
Xiaoya Zheng1, Teng Hu2, Tianxiang Fang1
1Health Science Center, Ningbo University, Ningbo, China.
Insights
Gastroesophageal reflux disease (GERD) is causally linked to myocardial infarction (MI). Hypertension and type-2 diabetes mellitus significantly mediate this association, suggesting improved cardiometabolic monitoring for GERD patients.
Area of Science:
- Cardiovascular Epidemiology
- Gastroenterology
- Genetic Epidemiology
Background:
- Observational studies suggest a link between gastroesophageal reflux disease (GERD) and myocardial infarction (MI).
- Causality and confounding factors in the GERD-MI relationship require further investigation.
- Understanding mediating factors is crucial for clinical management.
Purpose of the Study:
- To investigate the causal relationship between GERD and MI using Mendelian randomization.
- To identify and quantify the mediating effects of cardiovascular risk factors in the GERD-MI pathway.
- To inform clinical strategies for mitigating MI risk in GERD patients.
Main Methods:
- Two-sample Mendelian randomization (MR) analyses utilizing large-scale genome-wide association study data for GERD and MI.
- Multivariable MR to assess the independent effect of GERD on MI risk, adjusting for confounders.
- Two-step MR to investigate mediation pathways involving modifiable risk factors.
Main Results:
- A significant causal association was found between GERD and MI (OR=1.61, P < 10^-26).
- This association persisted after adjusting for body mass index, smoking, and alcohol consumption.
- Hypertension (14.4% mediation) and type-2 diabetes mellitus (12.0% mediation) were identified as significant mediators.
Conclusions:
- Modifiable cardiovascular risk factors, particularly hypertension and type-2 diabetes mellitus, mediate the causal link between GERD and MI.
- Integrated cardiometabolic monitoring is clinically important for GERD patients.
- Targeted management of blood pressure and glycemic control may reduce MI risk in individuals with GERD.
Background:
Observational studies have indicated that gastroesophageal reflux disease (GERD) is connected to myocardial infarction (MI). Nonetheless, the question of causality in these relationships remains unresolved, given the potential influence of confounding variables. The aim is to study the causal link of GERD with MI and determine whether MI factors have any mediation effects in the causative chain.
Methods:
GERD (129,080 cases and 473,524 controls) and MI (831,000 individuals) were obtained from the latest genome-wide association study summary-level data. Two-sample Mendelian randomization (MR) analyses were performed to assess the associations of genetically predicted GERD with MI risk. After adjusting for several confounders, multivariable MR was employed to determine the independent impacts of GERD on MI risk. Two-step MR analyses were carried out to investigate the mediating impacts of these modifiable factors in the relationships between GERD and MI.
Results:
The current univariable MR analysis indicated that GERD was connected to MI (odds ratio [OR] = 1.61; 95% confidence interval [CI]: 1.48-1.76; p = 1.01 × 10-26), whereas this correlation remained after controlling for body mass index, cigarettes per day, and alcohol consumption. Two-step MR found that several MI-associated risk factors mediated the associations between GERD and MI, with hypertension (mediation proportion: 14.4%) and type-2 diabetes mellitus (12.0%) exhibiting higher mediation proportions among the mediating networks.
Conclusion:
This study identifies modifiable cardiovascular risk factors that may mediate the GERD-MI association, with hypertension (14.4%) and T2DM (12.0%) identified as the predominant modifiable mediators. These findings highlight the clinical importance of integrated cardiometabolic monitoring in GERD patients, suggesting that targeted management of blood pressure and glycemic control may mitigate MI risk in GERD populations.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Mitral Regurgitation I: Introduction
Causality in Epidemiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology